SILVER LEVEL SPONSORS
To improve the field of Urology by developing best-in-class urology products and ensuring our customers can use them effectively.
To learn more please visit https://www.exactimaging.com/
About the Janssen Pharmaceutical Companies of Johnson & Johnson:
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular, Metabolism, & Retina; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension.
Learn more at www.janssen.com.
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden.
For more information, visit www.lantheus.com.
Accelerating the discovery, development and global access to radiopharmaceutical therapies.
To learn more please visit https://www.pointbiopharma.com/.
BRONZE LEVEL SPONSOR
Blue Earth Diagnostics, a subsidiary of Bracco Imaging, is a recognized leader in the development and commercialization of novel PET radio-pharmaceuticals to inform clinical management for cancer patients. Its portfolio includes a commercial product for recurrent prostate cancer and a robust pipeline of investigational agents.
For more information, visit: www.blueearthdiagnostics.com.
Mdxhealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on proprietary genetic, epigenetic and other complex molecular technologies.
Mdxhealth is dedicated to providing highly accurate and clinically actionable urologic solutions to inform patient diagnosis and treatment while improving healthcare economics for payers and providers.
For more information, visit: https://mdxhealth.com/
At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars across more than 30 indications.
Going forward, we are focused on delivering a next wave of breakthroughs in breast cancer,
genitourinary cancer, hematology and precision medicine.
To learn more visit: https://www.pfizer.com/science/focus-areas/oncology
Driven by purpose
At Philips, our purpose is to improve people’s health and well-being through meaningful innovation. We aim to improve 2.5 billion lives per year by 2030, including 400 million in underserved communities.
As a technology company, we – and our brand licensees – innovate for people with one consistent belief: there’s always a way to make life better.
For more information, visit: https://www.usa.philips.com/
At Siemens Healthineers, we pioneer breakthroughs in healthcare. For everyone. Everywhere. By constantly bringing breakthrough innovations to market, we enable healthcare professionals to deliver high-quality care, leading to the best possible outcome for patients.
Our portfolio, spanning from in-vitro and in-vivo diagnostics to image-guided therapy and innovative cancer care, is crucial for clinical decision-making and treatment pathways. With our strengths in patient twinning, precision therapy, as well as digital, data, and artificial intelligence (AI), we are well positioned to take on the biggest challenges in healthcare. We will continue to build on these strengths to help fight the world’s most threatening diseases, improving the quality of outcomes, and enabling access to care.
We are a team of 66,000 highly dedicated employees across more than 70 countries passionately pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.
For more information, visit: https://www.siemens-healthineers.com/
EXHIBITOR LEVEL SPONSOR
Avenda Health is creating a more personalized future of prostate cancer care. Using deep learning, Avenda Health software maps a patient’s cancer in 3D, giving physicians precise information and the confidence to make care decisions. Dedicated to bringing this cutting-edge technology to all practices and phsyicians treating prostate cancer patients, Avenda Health aims to improve outcomes, preserve quality of life, and create a new standard of cancer care.
To learn more visit us at www.avendahealth.com